BIRMINGHAM, Ala., July 27 /PRNewswire-FirstCall/ -- Emageon Inc. , a leading provider of enterprise visual medical systems to hospitals and healthcare networks, announced today that it has executed an agreement with CHRISTUS Health (CHRISTUS), a leading health system with facilities in seven states and Mexico.
Emageon and CHRISTUS announced the agreement to implement HeartSuite(TM), Emageon’s cardiology image management and visualization system across the network of 14 CHRISTUS facilities providing cardiovascular services. Emageon’s HeartSuite(TM) information system provides single-point access to cardiovascular patient data. CHRISTUS chose the Emageon HeartSuite(TM) solution after an exhaustive evaluation process led by an industry consultant. This announcement is the result of a full evaluation by CHRISTUS of multiple cardiology information systems vendors.
“We made the decision to partner with Emageon after an extensive review process,” said Alana Higgins, CHRISTUS’ Information Management Clinical Applications Manager. “Emageon’s cardiology solution allows for access to the complete cardiac patient record utilizing a comprehensive cardiovascular database providing optimized workflow.”
“CHRISTUS Health is consistently ranked as one of the most technically advanced healthcare systems in the United States,” said Chuck Jett, Emageon’s Chairman, CEO & President. “We share a common vision regarding the enterprise uses and demand for medical imaging with the talented team of clinicians and IT professionals at CHRISTUS. We are pleased and excited to extend our relationship with CHRISTUS throughout its enterprise.”
About CHRISTUS Health
Sponsored jointly by the Congregations of the Sisters of Charity of the Incarnate Word in Houston and the Sisters of Charity of the Incarnate Word in San Antonio, CHRISTUS Health is one of the largest Catholic health systems in the country, employing more than 25,000 people with total assets of $4.1 billion. With a mission to extend the healing ministry of Jesus Christ, CHRISTUS Health comprises over 40 hospitals and long-term care facilities, as well as dozens of other health services in more than 70 communities in Texas, Arkansas, Louisiana, Oklahoma, Georgia, Missouri and Utah, as well as in Monterrey and Saltillo, Mexico. CHRISTUS Health is headquartered in Dallas, Texas, with additional offices operating in both San Antonio and Houston to support the health system operations.
About Emageon Inc.
Emageon provides an enterprise-level advanced visualization and infrastructure solution for the clinical analysis and management of digital medical images for multi-hospital networks, community hospitals and diagnostic imaging centers. Emageon’s software provides physicians in multiple medical specialties such as cardiology, radiology, and orthopedics, among others, with dynamic tools to manipulate and analyze images in two and three dimensions. With these tools physicians have the ability to better understand internal anatomic structure and pathology, which can improve clinical diagnoses, disease screening and therapy planning. Emageon’s open standards-based solution is designed to help customers improve staff productivity, automate complex medical imaging workflow, lower total cost of ownership and provide better service to physicians and patients. For more information, please visit www.emageon.com.
This press release contains forward-looking statements about Emageon which represent the Company’s current views with respect to, among other things, future events and financial performance. Any forward-looking statements contained in this press release are based on Emageon’s historical performance and on current plans, beliefs and expectations. Actual results may differ materially from those expressed or implied by such forward-looking statements as a result of various risks, uncertainties and other factors beyond its control. These risks, uncertainties and other factors include, among others, the risk that it may not compete successfully against larger competitors, risks associated with its history of operating losses, the risk that it may not manage its growth effectively, the risk that acquisitions could result in integration difficulties, dilution or other adverse financial consequences, risks associated with its reliance on continuing relationships with large customers, the risk of significant product errors or product failures, its reliance on reseller arrangements for important components of its solution, the risk that it may not respond effectively to changes in its industry, its customers’ reliance on third party reimbursements, and the potential impact on its business of FDA regulations and other applicable health care regulations. Additional information concerning these and other factors that could affect Emageon’s financial and operating results may be found under the heading “Risk Factors” and elsewhere in the Company’s Form 10-K for the year ended December 31, 2005, which was filed with the Securities and Exchange Commission on March 31, 2006. Emageon undertakes no obligation to update these forward-looking statements or any other information provided in this press release except as may be required by law.
Emageon Inc.
CONTACT: Bill Funderburk of Emageon, +1-205-980-7542, orbill.funderburk@emageon.com
Web site: http://www.emageon.com//
